Bronchoscopes are used to examine and treat conditions of the airways and lungs. If you suffered a serious respiratory infection after a bronchoscopy using an Olympus bronchoscope, you may be eligible for legal action.
A bronchoscope is a thin, flexible endoscope designed to visualize the trachea, bronchi, and lower airways. Pulmonologists and critical care physicians use bronchoscopes for diagnostic procedures (biopsies, bronchoalveolar lavage), therapeutic interventions (foreign body removal, stent placement), and airway management in critically ill patients.
Bronchoscopes have narrow working channels and suction pathways that must be thoroughly reprocessed between patients. The small diameter of these channels—combined with exposure to respiratory secretions, blood, and tissue—makes contamination a significant concern. When reprocessing fails, the next patient may inhale contaminated material directly into their lungs.
Olympus produces widely used bronchoscope models including the BF-H190, BF-Q190, and BF-P190. These devices are deployed in hospitals, pulmonary clinics, and ICUs across the country. Claims against Olympus involve design features that may impede adequate reprocessing and allegations of insufficient warnings about contamination risks.
Olympus bronchoscopes and contamination risks
Bronchoscope contamination is particularly dangerous because the device delivers material directly into the respiratory tract. Unlike the GI tract, the lungs are a relatively sterile environment, meaning even small amounts of bacterial contamination can trigger serious infections including pneumonia, bronchitis, and invasive pulmonary infections.
The FDA has received reports of infections associated with reprocessed bronchoscopes, and studies have documented persistent contamination on bronchoscopes even after following manufacturer-recommended cleaning protocols. Olympus bronchoscope lawsuits allege that design features of the devices—narrow channels, difficult-to-access components—contribute to inadequate reprocessing.
For immunocompromised patients, transplant recipients, and ICU patients, bronchoscope-related infections can be life-threatening. These vulnerable populations are often the very patients most likely to require bronchoscopy, creating a heightened duty of care regarding device safety.
Injuries from contaminated bronchoscopes
Patients exposed to contaminated bronchoscopes may develop serious respiratory and systemic infections:
Pneumonia, including hospital-acquired and ventilator-associated pneumonia
Bronchitis and tracheobronchitis from direct airway contamination
Tuberculosis transmission in rare cases of severe reprocessing failure
Mycobacterial infections including nontuberculous mycobacteria (NTM)
Pseudomonas and other Gram-negative respiratory infections
Sepsis from respiratory infections that spread to the bloodstream
Death in vulnerable patients with compromised immune systems
Legal claims involving bronchoscopes
Bronchoscope lawsuits typically involve product liability claims centered on design defects (channels too narrow to clean effectively), failure to warn (inadequate reprocessing instructions for the specific contamination risks of respiratory scopes), and post-market negligence (failure to respond to adverse event reports involving bronchoscope-transmitted infections).
The severity of bronchoscope-related injuries—particularly in ICU patients and immunocompromised individuals—can support significant damage claims. The direct delivery of contaminants into the lungs makes these cases medically distinct from GI endoscope contamination.
Evidence for bronchoscope claims
Bronchoscopy procedure records identifying the Olympus bronchoscope model used
Respiratory cultures showing infection onset within 90 days of the procedure
ICU or hospital admission records following the bronchoscopy
Any hospital communications about bronchoscope contamination or infection clusters
Primary sources
When researching infection risk, reprocessing, or regulatory history, verify facts using official agency materials. Summaries on this site are for education and intake screening, not medical or legal advice.
Reprocessing reusable medical devices — U.S. Food and Drug Administration. FDA hub for flexible endoscope reprocessing requirements, labeling, and safety communications.
For overlapping questions about screening, timelines, and how Top Tier Legal connects inquiries with counsel, see the Olympus endoscope lawsuit FAQ on the main practice page rather than duplicating those answers on every procedure page.
If your situation involves an Olympus bronchoscope procedure and a qualifying injury, start your free, confidential case review below.
Top Tier Legal, LLC is not a law firm and does not provide legal advice. Submitting information does not create an attorney-client relationship. If you qualify, we may connect you with an independent law firm.
